VIDO-InterVac at the University of Saskatchewan. (Photo: Debra Marshall)

USask’s VIDO-InterVac and the National Research Council of Canada collaborate to advance development of vaccine against COVID-19

Posted on

Ce contenu n’est disponible qu’en anglais.

Key research and development organizations to leverage Canadian expertise and technologies in battle against COVID-19.

The University of Saskatchewan’s (USaskVaccine and Infectious Disease Organization-International Vaccine Centre (VIDO-InterVac) and the National Research Council of Canada (NRC) today announced a collaboration to work together to accelerate the development and production of a candidate COVID-19 antigen in mammalian cells…..
 

Read More Impact Stories

Posté le
Cet article n’est disponique qu’en anglais. B.C. researchers identify gene that fuels aggressive childhood cancers – UBC Faculty of Medicine [...]
Posté le
  Ce contenu n’est disponible qu’en anglais.
Posté le
L’étude montre un impact limité de la pandémie sur la santé mentale, soulignant la force de la résilience humaine. Selon [...]